Within the specific context of 30,000 new cases of oral and pharyngeal cancer diagnosed each year in the United States and the associated 9000 deaths is the broader picture of individuals with potentially detectable precancerous lesions. Most cases include patients with asymptomatic oral and oropharyngeal mucosal alterations.

Continue Reading